These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2120577)

  • 1. Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes.
    Near RI; Ng SC; Mudgett-Hunter M; Hudson NW; Margolies MN; Seidman JG; Haber E; Jacobson MA
    Mol Immunol; 1990 Sep; 27(9):901-9. PubMed ID: 2120577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M
    J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the heavy and light chain immunoglobulin variable region genes used in a set of anti-digoxin antibodies.
    Near RI; Haber E
    Mol Immunol; 1989 Apr; 26(4):371-82. PubMed ID: 2497340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regeneration of antidigoxin binding activity in an antibody by changes surrounding the original binding defect.
    Hudson NW; Albrecht M; Randhawa ZI; Steinrauf LK; Hamilton JA
    Mol Immunol; 1993 May; 30(7):685-93. PubMed ID: 8487784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.
    Near RI; Mudgett-Hunter M; Novotny J; Bruccoleri R; Ng SC
    Mol Immunol; 1993 Mar; 30(4):369-77. PubMed ID: 8455637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies.
    Mudgett-Hunter M; Anderson W; Haber E; Margolies MN
    Mol Immunol; 1985 Apr; 22(4):477-88. PubMed ID: 4033667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin chain recombination among antidigoxin antibodies by hybridoma-hybridoma fusion.
    Hudson NW; Mudgett-Hunter M; Panka DJ; Margolies MN
    J Immunol; 1987 Oct; 139(8):2715-23. PubMed ID: 3655369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine-specific antibodies: a model for T15-idiotype dominance.
    Kenny JJ; Moratz CM; Guelde G; O'Connell CD; George J; Dell C; Penner SJ; Weber JS; Berry J; Claflin JL
    J Exp Med; 1992 Dec; 176(6):1637-43. PubMed ID: 1460422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.
    Schildbach JF; Shaw SY; Bruccoleri RE; Haber E; Herzenberg LA; Jager GC; Jeffrey PD; Panka DJ; Parks DR; Near RI
    Protein Sci; 1994 May; 3(5):737-49. PubMed ID: 8061604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulations of anti-D affinity following promiscuous binding of the heavy chain with naïve light chains.
    St-Amour I; Proulx C; Lemieux R; Bazin R
    Transfusion; 2003 Feb; 43(2):246-53. PubMed ID: 12559021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies with different fine specificity for digoxin derivatives: cloning of heavy and light chain variable region sequences.
    Danielsson L; Furebring C; Ohlin M; Hultman L; Abrahamson M; Carlsson R; Borrebaeck CA
    Immunology; 1991 Sep; 74(1):50-4. PubMed ID: 1937573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A spontaneous variant of an antidigoxin hybridoma antibody with increased affinity arises from a heavy chain signal peptide mutation.
    Shaw SY; Margolies MN
    Mol Immunol; 1992 Apr; 29(4):525-9. PubMed ID: 1565100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of stable anti-digoxin Fv in Escherichia coli.
    Anthony J; Near R; Wong SL; Iida E; Ernst E; Wittekind M; Haber E; Ng SC
    Mol Immunol; 1992 Oct; 29(10):1237-47. PubMed ID: 1528194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant thyroid peroxidase-specific autoantibodies. I. How diverse is the pool of heavy and light chains in immunoglobulin gene libraries constructed from thyroid tissue-infiltrating plasma cells.
    Jaume JC; Costante G; Portolano S; McLachlan SM; Rapoport B
    Endocrinology; 1994 Jul; 135(1):16-24. PubMed ID: 8013349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ig H and L chain contributions to autoimmune specificities.
    Radic MZ; Mascelli MA; Erikson J; Shan H; Weigert M
    J Immunol; 1991 Jan; 146(1):176-82. PubMed ID: 1898596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector.
    Kanda H; Mori K; Koga H; Taniguchi K; Kobayashi H; Sakahara H; Konishi J; Endo K; Watanabe T
    Hybridoma; 1994 Oct; 13(5):359-66. PubMed ID: 7860092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M; Stollar BD
    J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
    Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
    J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.